Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain

Journal of Neuroimmunology

Volumn 131, Issue 1-2, 2002, Pages 135-146

  Strohmeyer, Ron ^a   Ramirez, Mauricio ^b   Cole, Gregory J ^b   Mueller, Kyle ^a   Rogers, Joseph ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Agrin; Alzheimer's; Amyloid ; Complement receptor 3; Factor H; Heparan sulfate proteoglycan

Indexed keywords

AGRIN; AMYLOID BETA PROTEIN; COMPLEMENT FACTOR H; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SENILE PLAQUE;

AGED; AGRIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE-1 ANTIGEN; NEUROGLIA;

EID: 0036789954     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00272-2     Document Type: Article

References (87)

1. Akiyama H., McGeer P.L. Brain microglia constitutively express beta-2 integrins. J. Neuroimmunol. 30:1990;81-93.
2. Akiyama H., Barger S., Barnum S., Brat B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
3. Archelos J.J., Previtali S.C., Hartung H.P. The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci. 22:1999;30-38.
4. Avery V.M., Gordon D.L. Characterization of factor H binding to human polymorphonuclear leukocytes. J. Immunol. 151:1993;5545-5553.
5. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
6. Barnum S.R. Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med. 6:1995;132-146.
7. Barrow C.J., Yasuda A., Kenny P.T., Zagorski M.G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225:1992;1075-1093.
8. Berger M., Wetzler E.M., Wallis R.S. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood. 71:1988;151-158.
9. Berzin T.M., Zipser B.D., Rafii M.S., Kuo-Leblanc V., Yancopoulos G.D., Glass D.J., Fallon J.R., Stopa E.G. Agrin and microvascular damage in Alzheimer's disease. Neurobiol. Aging. 21:2000;349-355.
10. Blackmore T.K., Hellwage J., Sadlon T.A., Higgs N., Zipfel P.F., Ward H.M., Gordon D.L. Identification of the second heparin-binding domain in human complement factor H. J. Immunol. 160:1998;3342-3348.
11. Brunden K.R., Richter-Cook N.J., Chaturvedi N., Frederickson R.C. pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans. J. Neurochem. 61:1993;2147-2154.
12. Buee L., Ding W., Anderson J.P., Narindrasorasak S., Kisilevsky R., Boyle N.J., Robakis N.K., Delacourte A., Greenberg B., Fillit H.M. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 627:1993;199-204.
13. Coria F., Castano E., Prelli F., Larrondo-Lillo M., van Duinen S., Shelanski M.L., Frangione B. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab. Invest. 58:1988;454-458.
14. Cotman S.L., Halfter W., Cole G.J. Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin. Exp. Cell Res. 249:1999;54-64.
15. Cotman S.L., Halfter W., Cole G.J. Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol. Cell. Neurosci. 15:2000;183-198.
16. Couturier C., Haeffner-Cavaillon N., Weiss L., Fischer E., Kazatchkine M.D. Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes. Eur. J. Immunol. 20:1990;999-1005.
17. DiScipio R.G., Daffern P.J., Schraufstatter I.U., Sriramarao P. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18). J. Immunol. 160:1998;4057-4066.
18. Donahue J.E., Berzin T.M., Rafii M.S., Glass D.J., Yancopoulos G.D., Fallon J.R., Stopa E.G. Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6468-6472.
19. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 382:1996;716-719.
20. El Khoury J., Hickman S.E., Thomas C.A., Loike J.D., Silverstein S.C. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 19:1998;S81-S84.
21. Fan S.T., Edgington T.S. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J. Immunol. 150:1993;2972-2980.
22. Flaherty S.F., Golenbock D.T., Milham F.H., Ingalls R.R. CD11/CD18 leukocyte integrins: new signaling receptors for bacterial endotoxin. J. Surg. Res. 73:1997;85-89.
23. Fukuchi K., Hart M., Li L. Alzheimer's disease and heparan sulfate proteoglycan. Front. Biosci. 3:1998;d327-d337.
24. Goodwin J.L., Kehrli M.E.J., Uemura E. Integrin Mac-1 and beta-amyloid in microglial release of nitric oxide. Brain Res. 768:1997;279-286.
25. Harler M.B., Wakshull E., Filardo E.J., Albina J.E., Reichner J.S. Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins. J. Immunol. 162:1999;6792-6799.
26. Hartung H.P., Hadding U., Bitter-Suermann D., Gemsa D. Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H. Clin. Exp. Immunol. 56:1984;453-458.
27. Hellwage J., Kuhn S., Zipfel P.F. The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity. Biochem. J. 326:1997;321-327.
28. Hellwage J., Skerka C., Zipfel P.F. Biochemical and functional characterization of the factor-H-related protein 4 (FHR-4). Immunopharmacology. 38:1997;149-157.
29. Holm Nielsen E., Nybo M., Junker K., Toftedal Hansen P., Rasmussen I.M., Svehag S.E. Localization of human serum amyloid P component and heparan sulfate proteoglycan in in vitro-formed Abeta fibrils. Scand. J. Immunol. 52:2000;110-112.
30. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
31. Iferroudjene D., Schouft M.T., Lemercier C., Gilbert D., Fontaine M. Evidence for an active hydrophobic form of factor H that is able to induce secretion of interleukin 1-beta or by human monocytes. Eur. J. Immunol. 21:1991;967-972.
32. Imamura T., Ohtsuka H., Matsushita M., Tsuruta J., Okada H., Kambara T. A new biological activity of the complement factor H: identification of the precursor of the major macrophage-chemotactic factor in delayed hypersensitivity reaction sites of guinea pigs. Biochem. Biophys. Res. Commun. 185:1992;505-509.
33. Jackson R.L., Busch S.J., Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:1991;481-539.
34. Jones L.S. Integrins: possible functions in the adult CNS. Trends Neurosci. 19:1996;68-72.
35. Kalaria R.N., Galloway P.G., Perry G. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 17:1991;189-201.
36. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;404-410.
37. Lindahl U. Proteoglycan structure and biosynthesis. Lander A., Nakato H., Selleck S.B., Turnbull J.E., Coath C. Cell Surface Proteoglycans in Signalling and Development. 1999;25-35 Human Frontier Science Program, Strasbourg.
38. Lorton D., Schaller J., Lala A., De Nardin E. Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease. Neurobiol. Aging. 21:2000;463-473.
39. Magnus J.H., Stenstad T. Proteoglycans and the extracellular matrix in amyloidosis. Amyloid. 4:1997;121-134.
40. Mahley R.W., Ji Z.S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40:1999;1-16.
41. Malhotra R., Ward M., Sim R.B., Bird M.I. Identification of human complement factor H as a ligand for L-selectin. Biochem. J. 341:1999;61-69.
42. Maresh G.A., Erezyilmaz D., Murry C.E., Nochlin D., Snow A.D. Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction. J. Neurochem. 67:1996;1132-1144.
43. McGeer P.L., McGeer E.G. Complement proteins and complement inhibitors in Alzheimer's disease. Res. Immunol. 143:1992;621-624.
44. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33:1998;371-378.
45. McGeer P.L., McGeer E.G. Mechanisms of cell death in Alzheimer disease - immunopathology. J. Neural Transm., Suppl. 54:1998;159-166.
46. Medvedev A.E., Flo T., Ingalls R.R., Golenbock D.T., Teti G., Vogel S.N., Espevik T. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 160:1998;4535-4542.
47. Meri S., Jarva H. Complement regulation. Vox Sang. 74:1998;291-302.
48. Meri S., Pangburn M.K. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. Biochem. Biophys. Res. Commun. 198:1994;52-59.
49. Nabil K., Rihn B., Jaurand M.C., Vignaud J.M., Ripoche J., Martinet Y., Martinet N. Identification of human complement factor H as a chemotactic protein for monocytes. Biochem. J. 326:1997;377-383.
50. Neuman E., Huleatt J.W., Jack R.M. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils. J. Immunol. 145:1990;3325-3332.
51. Ohtsuka H., Imamura T., Matsushita M., Tanase S., Okada H., Ogawa M., Kambara T. Thrombin generates monocyte chemotactic activity from complement factor H. Immunology. 80:1993;140-145.
52. O'Neill L.A., Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
53. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron. 17:1996;553-565.
54. Partrick D.A., Moore E.E., Moore F.A., Barnett C.C., Silliman C.C. Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils. J. Trauma. 43:1997;297-302.
55. Perez R.L., Ritzenthaler J.D., Roman J. Transcriptional regulation of the interleukin-1beta promoter via fibrinogen engagement of the CD18 integrin receptor. Am. J. Respir. Cell Mol. Biol. 20:1999;1059-1066.
56. Perlmutter L.S., Chui H.C. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res. Bull. 24:1990;677-686.
57. Prodinger W.M., Wurzner R., Erdei A., Dierich M. Complement. Paul W.E. Fundamental Immunology. 4th ed. 1999;967-995 Lippincott-Raven, Philadelphia.
58. Reilly C.E. Crucial role of heparan sulfate proteoglycan (agrin) in beta-amyloid formation in Alzheimer's disease. J. Neurol. 247:2000;663-664.
59. Rezzonico R., Chicheportiche R., Imbert V., Dayer J.M. Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood. 95:2000;3868-3877.
60. Ricevuti G., Mazzucchelli I., Gritti D., Canale C., Pistone C., Intili M., Montagna M., Fossati G. Over expression of alpha M beta 2 integrin on peripheral blood human neutrophils stimulated with GM-CSF. Eur. J. Histochem. 41:1997;41-42.
61. Rogers J., Griffin W.S.T. Inflammatory mechanisms of Alzheimer's disease. Wood P.L. Neuroinflammation: Mechanisms and Management. 1998;177-193 Humana Press, New Jersey.
62. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
63. Shappell S.B., Toman C., Anderson D.C., Taylor A.A., Entman M.L., Smith C.W. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J. Immunol. 144:1990;2702-2711.
64. Shuvaev V.V., Siest G. Heparin specifically inhibits binding of apolipoprotein E to amyloid beta-peptide. Neurosci. Lett. 280:2000;131-134.
65. Shuvaev V.V., Laffont I., Siest G. Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix. FEBS Lett. 459:1999;353-357.
66. Sitrin R.G., Pan P.M., Srikanth S., Todd R.F. Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J. Immunol. 161:1998;1462-1470.
67. Small D.H., Nurcombe V., Reed G., Clarris H., Beyreuther K., Masters C.L. The role of the extracellular matrix in regulating the function of the amyloid protein precursor of Alzheimer's disease. Masters C.L.et al. Amyloid Protein Precursor, Ageing and Alzheimer's Disease. 1994;65-75 Springer-Verlag, Berlin.
68. Snow A.D., Wight T.N. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol. Aging. 10:1989;481-497.
69. Snow A.D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T.N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133:1988;456-463.
70. Snow A.D., Mar H., Nochlin D., Sekiguchi R.T., Kimata K., Koike Y., Wight T.N. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137:1990;1253-1270.
71. Snow A.D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W.A., Morgan D.G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron. 12:1994;219-234.
72. Snow A.D., Sekiguchi R.T., Nochlin D., Kalaria R.N., Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am. J. Pathol. 144:1994;337-347.
73. Strohmeyer R., Rogers J. Molecular and cellular mediators of Alzheimer's disease inflammation. J. Alzheimer's Dis. 3:2001;131-157.
74. Strohmeyer R., Shen Y., Rogers J. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Brain Res., Mol. Brain Res. 81:2000;7-18.
75. Su J.H., Cummings B.J., Cotman C.W. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience. 51:1992;801-813.
76. Tanaka Y., Adams D.H., Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol. Today. 14:1993;111-115.
77. Tanaka Y., Kimata K., Adams D.H., Eto S. Modulation of cytokine function by heparan sulfate proteoglycans: sophisticated models for the regulation of cellular responses to cytokines. Proc. Assoc. Am. Physicians. 110:1998;118-125.
78. Thieblemont N., Haeffner-Cavaillon N., Haeffner A., Cholley B., Weiss L., Kazatchkine M.D. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells. J. Immunol. 155:1995;4861-4867.
79. 2 - by human neutrophils via a complement iC3b/Mac-1 interaction. Biol. Signals. 2:1993;126-135.
80. Verbeek M.M., Otte-Holler I., van den Born J., van den Heuvel L.P., David G., Wesseling P., de Waal R.M. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am. J. Pathol. 155:1999;2115-2125.
81. Wulczyn F.G., Krappmann D., Scheidereit C. The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation. J. Mol. Med. 74:1996;749-769.
82. Wyss-Coray T., Yan F., Hsiu-Ti Lin A., Lambris J.D., Alexander J.J., Quigg R.J., Masliah E. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc. Natl. Acad. Sci. U. S. A. 2002;10837-10842.
83. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
84. Yan S.D., Zhu H., Fu J., Yan S.F., Roher A., Tourtellotte W.W., Rajavashisth T., Chen X., Godman G.C., Stern D., Schmidt A.M. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5296-5301.
85. Zipfel P.F., Skerka C. Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol. Today. 15:1994;121-126.
86. Zipfel P.F., Skerka C. FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function. Immunol. Today. 20:1999;135-140.
87. Zipfel P.F., Jokiranta T.S., Hellwage J., Koistinen V., Meri S. The factor H protein family. Immunopharmacology. 42:1999;53-60.